Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model

D. C. Gritz, P. J. McDonnell, T. Y. Lee, D. Tang-Liu, B. B. Hubbard, A. Gwon

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Ofloxacin, a new quinolone antibiotic with a broad spectrum of activity, is very effective against Pseudomonas aeruginosa in vitro. Its effectiveness was studied in a rabbit model of tobramycin-sensitive P. aeruginosa. Treatment groups received either vehicle, tobramycin 0.3%, or ofloxacin 0.3%. Twelve hours of treatment decreased the bacterial counts from a mean of 2.2 ± 0.7 x 106 colony forming units (cfu) per cornea in the vehicle group to means of 513 ± 670 and 435 ± 524 cfu in the tobramycin and ofloxacin groups, respectively. This decrease in bacterial counts was statistically significant (p = 0.001 for tobramycin and ofloxacin each compared with control, p = 0.86 for tobramycin compared with ofloxacin). After seven days, all antibiotic-treated corneas were sterile and the epithelial defects healed at comparable rates. Aqueous humor drug levels were higher in infected eyes without an intact epithelium (p = 0.02); in eyes with intact epithelium, concentrations of ofloxacin were higher than were those of tobramycin (p = 0.002). In this animal model, ofloxacin proved to be an effective antibiotic with no evidence of toxicity.

Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
Issue number2
StatePublished - Jan 1 1992

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model'. Together they form a unique fingerprint.

Cite this